VAR Review with Dr. Bixby: Reversing the Call on MPAL
In this episode, Anthony and Bernie are joined by the great Dr. Bixby to discuss the difficulties in the diagnosis and treatment of acute leukemias of mixed or ambiguous lineage (ALAL/MPAL). We discus...
1 Juli 1h 6min
Bispecifics ate CAR-T's lunch: a multiple myeloma debate
In this episode, Bernie and Anthony are joined by Myeloma Man Manni Mohyuddin, MD to discuss the debate surrounding the treatment of first relapse in multiple myeloma. Should we be using CAR-T? Bispec...
11 Juni 56min
Spring Cleaning the Evidence from ASH 2025 with Common Sense Oncology
In this special video episode, Bernie and Anthony moderate a Common Sense Oncology discussion of key trials from ASH 2025! We are joined by special guest experts from across the globe to critically ap...
13 Apr 1h 1min
HLH: From Chaos to Clarity... and Back to Chaos!
In this episode, Anthony and Bernie are joined by a panel of experts to discuss (and debate) everyone's favorite (or most feared) hematology topic - hemophagocytic lymphohistiocytosis (HLH)! Joining u...
20 Mars 1h 4min
An Exercise in Uncertainty with Jonathan Gluck
Anthony and Bernie are joined by special guest Jonathan Gluck, award-winning journalist and author of "An Exercise in Uncertainty: A Memoir of Illness and Hope" for a powerful conversation about livin...
10 Feb 46min
ASH Leukemia Review: the more we learn, the less we know!
In this episode, Anthony and Bernie are joined by special guest, Dr. Justin Kaner from Weill Cornell Medicine, to discuss some of the most interesting ASH abstracts in leukemia in 2025! What abstracts...
17 Dec 20251h 23min
RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy
Anthony and Bernie discuss the PARADIGM study that was presented at the plenary session of ASH 2025 and whether results should change our practice. https://meetings-api.hematology.org/api/abstract/vmp...
9 Dec 202541min
